December « 2015 « Science and Enterprise

Computer Vision Devised as Drug Discovery Technique

By Alan, on December 15th, 2015%

(Melmark, Pixabay)

15 December 2015. Pharmaceutical chemists at University of California in San Francisco developed techniques for adapting computer vision, like those used in robotics, to early-stage drug discovery. The team led by UC-San Francisco’s Steven Altschuler and Lani Wu describe its discovery in yesterday’s issue of the journal Nature Biotechnology (paid subscription . . . → Read More: Computer Vision Devised as Drug Discovery Technique

Hitting the Road

By Alan, on December 14th, 2015%

(John St John/Flickr)

14 December 2015. Science and Enterprise is returning from a conference this weekend, so we will have no posts today. We’ll continue with our regular posting tomorrow.

* * *

Spin-Off Developing Gene Therapies for Blood Disorders

By Alan, on December 11th, 2015%

Red blood cells illustration (geralt, Pixabay)

11 December 2015. A new spin-off company from University College London in the U.K. is developing gene therapies to treat hemophilia and related diseases. The company, Freeline Therapeutics, is raising £25 million ($US 38 million) in its first venture funding round.

Freeline Therapeutics is founded and commercializing . . . → Read More: Spin-Off Developing Gene Therapies for Blood Disorders

More PhDs Heading to Industry, Improve Earnings

By Alan, on December 11th, 2015%

Molecular biology lab at Eli Lilly and Co. in New York (A. Kotok)

11 December 2015. An analysis of recent grant-funded Ph.D. recipients shows a large number of new doctorates taking jobs in industry, particularly with larger companies paying higher salaries. The study of federal and other grant-supported doctorates, conducted by researchers at . . . → Read More: More PhDs Heading to Industry, Improve Earnings

Biotech to Explore Gut-Brain Connections, Raises $44M

By Alan, on December 10th, 2015%

Brain wiring illustration (Courtesy, Human Connectome Project and NIH)

10 December 2015. A new biotechnology start-up plans to derive medical and consumer products from interactions between the human gut and brain. Kallyope Inc. in New York City is founded by biomedical researchers at Columbia University and raising $44 million its first venture funding . . . → Read More: Biotech to Explore Gut-Brain Connections, Raises $44M

Nanotech Multi-Drug Delivery Technique Devised for Cancer

By Alan, on December 10th, 2015%

(PDPics/Pixabay)

10 December 2015. A pharmacy lab at Oregon State University developed a technique for combining three drugs into nanoscale particles that treat melanoma spreading to lymph nodes in lab animals. The team led by Oregon State pharmacy professor Adam Alani published its proof-of-concept findings last month in Journal of Controlled Release (paid . . . → Read More: Nanotech Multi-Drug Delivery Technique Devised for Cancer

Researchers Develop Eye Injury Test, Start Company

By Alan, on December 9th, 2015%

OcuCheck biosensor (L. Brian Stauffer, University of Illinois – Champaign)

9 December 2015. A medical and engineering team at University of Illinois in Champaign designed a sensor providing a quick, portable test for the severity of eye injuries. The researchers led by bioengineering professor Dipanjan Pan and ophthalmologist Leanne Labriola at Carle Foundation . . . → Read More: Researchers Develop Eye Injury Test, Start Company

University Spin-Off Develops Pain Killer Patch

By Alan, on December 8th, 2015%

Medherant ibuprofen skin patch (University of Warwick)

8 December 2015. A new company begun by a chemistry professor in the U.K. is developing a patch infused with ibuprofen for people needing relief from pain or inflammation from arthritis. Medherant Ltd., in Coventry, is developing the patch based on research at University of Warwick . . . → Read More: University Spin-Off Develops Pain Killer Patch

High Blood Cancer Response Rates Found for Cell Therapies

By Alan, on December 8th, 2015%

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

8 December 2015. Two clinical trials of personalized immune cells to treat blood-related cancers — acute lymphoblastic leukemia in children and non-Hodgkin lymphoma in adults — showed high rates of response and remission. Results of the two . . . → Read More: High Blood Cancer Response Rates Found for Cell Therapies

Advocacy Group, Genetics Company Partner on Brain Disorder

By Alan, on December 7th, 2015%

(National Heart, Lung, and Blood Institute, NIH)

7 December 2015. The start-up genetics analysis company Pairnomix is collaborating with KCNQ2 Cure Alliance to better understand mutations leading to KCNQ2 epileptic encephalopathy, an inherited brain disorder. Financial and intellectual property aspects of the partnership were not disclosed.

KCNQ2 epileptic encephalopathy is a rare condition . . . → Read More: Advocacy Group, Genetics Company Partner on Brain Disorder

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise